Date published: 2025-12-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

CD9P-1 Activators

CD9P-1 activators encompass a variety of chemical compounds that indirectly augment its functional activity through distinct biochemical pathways, central to cell-cell interactions and adhesion processes. Compounds like Phorbol 12-myristate 13-acetate (PMA) and Forskolin play pivotal roles in this enhancement. PMA, as a protein kinase C (PKC) activator, directly influences the phosphorylation of substrates involved in CD9P-1 mediated pathways, crucial for immune and endothelial cell interactions. Forskolin, elevating intracellular cAMP levels, indirectly augments CD9P-1's functionality by activating protein kinase A (PKA), which phosphorylates key proteins in pathways where CD9P-1 is essential, such as intercellular communication. Similarly, Ionomycin enhances CD9P-1 activity by increasing intracellular calcium, pivotal for calcium-dependent signaling pathways in which CD9P-1 plays a significant role. Inhibitors like LY294002 and PD98059, targeting PI3K and MEK respectively, alter crucial signaling pathways, indirectly fostering environments conducive to CD9P-1's role in cell migration and adhesion. These chemical interactions indicate a complex network of signaling pathways converging at CD9P-1, emphasizing its integral role in cellular processes.

Continuing the exploration of CD9P-1 activators, compounds like Staurosporine, Sphingosine-1-phosphate, and Thapsigargin further demonstrate the intricate modulation of CD9P-1's activity. Staurosporine, a broad-spectrum kinase inhibitor, potentially enhances CD9P-1's functions by selectively lifting inhibitions exerted by specific kinases on CD9P-1 related processes. The involvement of lipid signaling, as influenced by Sphingosine-1-phosphate, potentiates CD9P-1's role in cellular adhesion, while Thapsigargin, by modulating intracellular calcium levels, further accentuates its function in cell signaling. MEK inhibitors like U0126 and p38 MAPK inhibitor SB203580, by shifting the signaling balance, enhance pathways involving CD9P-1, particularly under stress conditions. Additionally, the influence of tyrosine kinase inhibitor Genistein and Epigallocatechin gallate (EGCG) underscores the diverse molecular interactions that enhance CD9P-1's role in cell communication and adhesion. Collectively, these activators underscore the multifaceted role of CD9P-1 in cellular processes, particularly highlighting its importance in cell adhesion and communication through the modulation of various signaling pathways.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA, a potent PKC activator, enhances CD9P-1 activation. PKC plays a crucial role in CD9P-1 mediated cell-cell interactions, particularly in immune and endothelial cells, by phosphorylating substrates that influence these interactions.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin increases intracellular cAMP levels, which indirectly augments CD9P-1 functionality. Elevated cAMP activates PKA, which can phosphorylate key proteins involved in pathways where CD9P-1 is critical, such as intercellular communication and adhesion.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin, a calcium ionophore, enhances CD9P-1 activity by increasing intracellular calcium levels, which is essential for the activation of calcium-dependent signaling pathways involved in CD9P-1 mediated cell adhesion and signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002, a PI3K inhibitor, indirectly influences CD9P-1 activity by modulating the PI3K/AKT pathway, crucial for several cellular processes in which CD9P-1 is involved, such as cell migration and adhesion.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059, an MEK inhibitor, alters the MAPK/ERK pathway. By inhibiting this pathway, the equilibrium shifts, potentially enhancing pathways where CD9P-1 is active, particularly in cellular communication and adhesion processes.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine, a broad-spectrum kinase inhibitor, can lead to selective activation of CD9P-1 pathways by reducing the inhibition exerted by specific kinases on processes related to CD9P-1.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

Sphingosine-1-phosphate engages in lipid signaling, which can potentiate CD9P-1 mediated functions in cellular adhesion and communication by activating or modulating sphingolipid pathways that intersect with CD9P-1 functions.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin, by increasing intracellular calcium levels, enhances CD9P-1 activity. This elevation in calcium activates pathways crucial for cell adhesion and signaling, where CD9P-1 plays a significant role.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580, a p38 MAPK inhibitor, alters signaling pathways, potentially enhancing those in which CD9P-1 is active, particularly in stress response and cellular communication.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein, a tyrosine kinase inhibitor, can enhance CD9P-1 activity by reducing competition from tyrosine kinase signaling, thus favoring pathways where CD9P-1 is involved in cell communication and adhesion.